William Goolsbee
Director/Board Member presso HELIX BIOMEDIX, INC.
Profilo
William Alden Goolsbee was the founder of Horizon Medical, Inc. (founded in 1987) where he held the title of Chairman & Chief Executive Officer in 2002.
He is currently the Chairman & Chief Executive Officer at BMG Hematology LLC and an Independent Director at Helix BioMedix, Inc. He previously served as Chairman of Immunotherapy Corp.
from 1995 to 1998, Chairman of BMG Pharma LLC from 2006 to 2011, Chairman of Metrodora Therapeutics, Inc., Independent Director at Sarepta Therapeutics, Inc. from 2014 to 2016, and Independent Non-Executive Director at Percheron Therapeutics Ltd.
from 2015 to 2021.
Mr. Goolsbee obtained his undergraduate degree from the University of California, Santa Barbara.
Posizioni attive di William Goolsbee
| Società | Posizione | Inizio |
|---|---|---|
| HELIX BIOMEDIX, INC. | Director/Board Member | 01/01/2019 |
| BMG Hematology LLC | Chief Executive Officer | - |
Precedenti posizioni note di William Goolsbee
| Società | Posizione | Fine |
|---|---|---|
| PERCHERON THERAPEUTICS LIMITED | Director/Board Member | 15/12/2021 |
| SAREPTA THERAPEUTICS, INC. | Chairman | 30/07/2014 |
| Metrodora Therapeutics, Inc. | Chairman | 01/01/2015 |
| BMG Pharma LLC | Chairman | 01/01/2011 |
| Horizon Medical, Inc. | Chief Executive Officer | 01/01/2002 |
Formazione di William Goolsbee
| University of California, Santa Barbara | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| HELIX BIOMEDIX, INC. | Health Technology |
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| PERCHERON THERAPEUTICS LIMITED | Health Technology |
| Aziende private | 5 |
|---|---|
| Horizon Medical, Inc. | Health Technology |
Immunotherapy Corp.
 Immunotherapy Corp. Pharmaceuticals: OtherHealth Technology Part of Sarepta Therapeutics, Inc., Immunotherapy Corp. develops cancer treatments. The private company is based in Seattle, WA. The CEO of the company is Amnon Gonenne. Immunotherapy was acquired by AntiVirals, Inc. on November 06, 1997 for $24 million. | Health Technology |
| BMG Pharma LLC | |
| BMG Hematology LLC | |
| Metrodora Therapeutics, Inc. |
- Borsa valori
- Insiders
- William Goolsbee
